![[SONDA] What can be done to effectively spend on hematooncology? - Header image](https://cdn.medexpress.pl/media/images/416055261_67542499146.2e16d0ba.fill-950x430.format-webp.webp)
- Patients with hemato-oncology diseases deserve to be treated with the latest methods, the parlementarians who spoke in a poll conducted by Medexpress in the parliamentary corridors agree. Among other things, we asked them about the importance of effective use of financial inputs in this field of medicine.
- There has been tremendous progress in hematooncology, both adult and pediatric. Knowledge in this field is rushing forward so much that methods that were used in the past are now obsolete. That's why it's so important to quickly get modern drugs, both biologic drugs and signaling pathway drugs, onto reimbursement lists. Today it is still taking too long in Poland. Patients deserve to be treated with the latest methods," said Prof. Alicja Chybicka, member of the P...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
